Coagulation and inflammatory markers in Alzheimer's and vascular dementia

被引:68
作者
Gupta, A [1 ]
Watkins, A
Thomas, P
Majer, R
Habubi, N
Morris, G
Pansari, K
机构
[1] W Wales Hosp, Dept Med, Carmarthen SA31 2AF, Dyfed, Wales
[2] Univ Swansea, Dept Stat, Swansea, W Glam, Wales
[3] Prince Philip Hosp, Dept Med, Llanelli, Wales
[4] Prince Philip Hosp, Dept Haematol, Llanelli, Wales
[5] Prince Philip Hosp, Dept Pathol, Llanelli, Wales
[6] St Davids Hosp, Carmarthen, Dyfed, Wales
关键词
dementia; coagulation; inflammation;
D O I
10.1111/j.1368-5031.2004.00143.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alzheimer's disease is classified as a degenerative dementia while vascular dementia is known to be associated with atherothrombosis and classical vascular risk factors. However, over the last decade, there is increasing evidence of the role of haemostatic factors and inflammatory mechanisms in the pathogenesis of Alzheimer's disease. Serum markers of hyper-coagulability and markers of inflammation could lead to thrombosis, accelerated atherogenesis and resulting dementia of both Alzheimer's and vascular dementia. In this case control study, we studied these serum markers of coagulation and inflammation in patients suffering from dementia.(C) 2004 Blackwell Publishing Ltd.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 61 条
[51]   Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study [J].
Smith, FB ;
Lee, AJ ;
Fowkes, FGR ;
Price, JF ;
Rumley, A ;
Lowe, GDO .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :3321-3325
[52]  
Spada RS, 2001, ARCH GERONTOL GERIAT, P369
[53]   Haemostasis in ischaemic stroke and vascular dementia [J].
Stott, DJ ;
Spilg, E ;
Campbell, AM ;
Rumley, A ;
Mansoor, MA ;
Lowe, GDO .
BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (08) :651-657
[54]   Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions [J].
Tsuda, Y ;
Satoh, K ;
Kitadai, M ;
Takahashi, T .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 147 (01) :49-54
[55]   Lipoprotein(a) phenotypes in patients with vascular dementia [J].
Urakami, K ;
Wada-Isoe, K ;
Wakutani, Y ;
Ikeda, K ;
Ji, Y ;
Yamagata, K ;
Kowa, H ;
Okada, A ;
Adachi, Y ;
Nakashima, K .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (03) :135-138
[56]   COAGULATION, FIBRINOLYTIC, AND INHIBITORY PROTEINS IN ACUTE MYOCARDIAL-INFARCTION AND ANGINA-PECTORIS [J].
VAZIRI, ND ;
KENNEDY, SC ;
KENNEDY, D ;
GONZALES, E .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (06) :651-657
[57]   IMPROVED NEUROLOGICAL RECOVERY OF CEREBRAL INFARCTIONS AFTER PLASMAPHERETIC REDUCTION OF LIPIDS AND FIBRINOGEN [J].
WALZL, M ;
LECHNER, H ;
WALZL, B ;
SCHIED, G .
STROKE, 1993, 24 (10) :1447-1451
[58]   A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in stanford five-city project participants [J].
Wild, SH ;
Fortmann, SP ;
Marcovina, SM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (02) :239-245
[59]   Cholesterol, endothelial function and cardiovascular disease [J].
Wilkinson, IB ;
Cockcroft, JR .
CURRENT OPINION IN LIPIDOLOGY, 1998, 9 (03) :237-242
[60]   FIBRINOGEN, VISCOSITY, AND WHITE BLOOD-CELL COUNT ARE MAJOR RISK-FACTORS FOR ISCHEMIC-HEART-DISEASE - THE CAERPHILLY AND SPEEDWELL COLLABORATIVE HEART-DISEASE STUDIES [J].
YARNELL, JWG ;
BAKER, IA ;
SWEETNAM, PM ;
BAINTON, D ;
OBRIEN, JR ;
WHITEHEAD, PJ ;
ELWOOD, PC .
CIRCULATION, 1991, 83 (03) :836-844